ArticleAngewandte Chemie (International ed. in English)2026
Cobalt-Catalyzed Reductive Asymmetric Dimerization of 1,3-Enynes: Rapid Synthesis of Enantioenriched Skipped 1,3,6-Trienes.
Article in Angewandte Chemie (International ed. in English), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Enantioenriched skipped polyenes represent an important building block in natural products and bioactive molecules. Thus, it is of great importance for developing efficient methods for the synthesis of enantioenriched skipped polyenes yet challenging. To date, no example for direct access to skipped polyenes with controlled stereochemistry from simple and readily available starting materials has been developed. Herein, a cobalt-catalyzed reductive asymmetric cross-dimerization of 1,3-enynes has been developed, affording the first rapid access to enantioenriched skipped 1,3,6-trienes from readily available simple starting materials. Moreover, this protocol is amenable to enantioenriched skipped dienes by asymmetric reductive cross-hydrodimerization of 1,3-enynes with alkynes. Mechanistic investigations revealed a domino process by a chemoselective and non-regioselective semi-reduction of 1,3-enynes to 1,3-dienes followed by a chemo-, regio-, and enantioselective cross-hydrodimerization of 1,3-dienes with 1,3-enynes. Notably, asymmetric reductive hydrodimerization of enynes represents the first example of synthesizing enantioenriched 1,3,6-trienes, 1,3,5,8,10-pentaenes, 1,4-dienes from achiral starting materials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.